Vitamin D Levels in Women With Polycystic Ovary Syndrome

Ghamra Military Hospital90 enrolled

Overview

Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%. Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.

The aim of this work is assessment of the level of vitamin D in female have polycystic ovary syndrome \& healthy female.and also make diagnostic criteria for patient who is in need for supplementations with vitamin D.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Polycystic Ovary Syndrome

Interventions

Vitamin D Levels measurement using chemiluminescent assayDRUG

Measurement of serum vitamin D levels

Vitamin D level assessmentDEVICE

Using lIAISON DEVICE

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 35 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion criteria: * Hyperandrogenism * Polycystic ovary syndrome Exclusion Criteria: * Thyroid disease * Parathyroid disease * Diabetes Mellitus * Cushing syndrome * Congenital adrenal hyperplasia * Hyperprolactinemia * Renal, liver or chronic disease

Locations (1)

Misr Al Gadida Military hospital

Cairo, Egypt

Outcomes

Primary Outcomes

Levels of vitamin D in Polycystic ovary syndrome

vitamin D levels is assumed to be significantly decreased

Time frame: 1 year

Secondary Outcomes

Levels of vitamin D in fertile women

vitamin D level is expected to be normal

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.